First treatment approved for breast cancer with BRCA genetic mutation

The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the […]

Related:
FDA warns against giving kids cough and cold medicines with codeine or hydrocodone
New study on abortion pill shows high success, low rate of complications
He was 21 and fit. He tried to push through the flu — and it killed him.

Share Share Tweet Share Share Share

Home

Thanks For You Reading The Post We are very happy for you to come to our site. Our Website Domain name https://leomedtrends.blogspot.com/.